Physician profile
Michael E Pinson
NPI 1760476212
$5,749.75
in general payments reported to CMS, 2019-2025
28 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2020: $688 · 2021: $623 · 2022: $1,017 · 2023: $662 · 2024: $792 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $791.80 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $625.78 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $618.02 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $525.06 | 2019-2025 | |
| Boston Scientific Corporation | $483.59 | 2019-2022 | |
| Pfizer INC. | $456.92 | 2019-2025 | |
| Medtronic, INC. | $415.02 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals Lp | $263.39 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.79 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $200.86 | 2019-2024 | Xarelto |
| Amgen INC. | $138.50 | 2019-2025 | Repatha |
| Philips North America LLC | $127.28 | 2022-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Irhythm Technologies, INC. | $99.06 | 2024 | Zio Monitor, Zio Xt Patch |
| Amarin Pharma, INC. | $97.40 | 2019-2021 | |
| Chiesi USA, INC. | $88.77 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $88.70 | 2019-2024 | Mini Trek |
| Actelion Pharmaceuticals US, INC. | $87.28 | 2020-2022 | |
| Cardiva Medical, INC. | $76.82 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $68.56 | 2020 | |
| Braemar Manufacturing, LLC | $64.57 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $44.58 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $40.45 | 2020 | |
| Ethicon US, LLC | $28.41 | 2025 | Surgicel Nu-Knit, Vistaseal, Dermabond Prineo |
| Impulse Dynamics (USA) INC. | $24.23 | 2023 | Optimizer |
| Abiomed | $21.03 | 2020 | |
| Gilead Sciences, INC. | $13.94 | 2019 | |
| Penumbra, INC. | $12.55 | 2022 | |
| Alnylam Pharmaceuticals INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.